---

$1.84

+0.1050 ( +6.07% ) 440.7K

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-08-02	Sale	-81928.00	Girolamo Todd C
2024-07-29	Sale	-826.00	Weber Darin J.
2024-06-25	Buy	8264462.00	Control Empresarial de Capitales S.A. de C.V.
2024-06-20	Sale	-17238.00	Weber Darin J.
2024-06-14	Buy	22617909.00	Legorreta Pablo G.